This approximately 3.3-year study is testing a once-daily oral tablet to see if it can lower the risk of serious heart problems and protect kidney health in adults aged 50 and older with heart or kidney disease.
This study is being conducted at our Western Sydney and Canberra, sites.
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
